# FDA Inspection 1191477 - South Texas Blood & Tissue Center - November 21, 2022

Source: https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/95cd3c95-d4e2-4e1a-b8a6-620e3e5e1de1
Source feed: FDA_Inspections

> FDA Inspection 1191477 for South Texas Blood & Tissue Center on November 21, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191477
- Company Name: South Texas Blood & Tissue Center
- Inspection Date: 2022-11-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191477 - 2022-11-21](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/9b39472a-09af-4bb3-9e55-485e4bda5489)
- [FDA Inspection 1076961 - 2019-01-16](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/94ab3253-2df7-463d-a54c-91ab95760585)
- [FDA Inspection 1028900 - 2017-09-01](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/ea090ba0-0e9a-4b53-b4d7-41707d801efc)
- [FDA Inspection 938887 - 2015-07-08](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/467aaa37-4efe-4b19-a60b-19d915d0a082)
- [FDA Inspection 808724 - 2012-11-28](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/5ebb23b7-bccd-4b1b-a2f8-8acf9c90af2a)

Company: https://www.keypedia.com/companies/south-texas-blood-tissue-center/3b161c01-1d58-4e4b-860c-0b5d553741d5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d